Press releases Press releases Year None20212020201920182017201620152014 Jun 15, 2021 Otonomy Initiates Expansion of Phase 1/2 Clinical Trial for OTO-413 in Hearing Loss May 14, 2021 Otonomy and AGTC Present Preclinical Proof-of-Concept Results for OTO-825 Gene Therapy at ASGCT Annual Meeting May 11, 2021 Otonomy Reports First Quarter 2021 Financial Results and Provides Corporate Update May 04, 2021 Otonomy to Report First Quarter 2021 Financial Results and Provide Corporate Update Apr 28, 2021 Otonomy and AGTC to Present Preclinical Proof-of-Concept Results for OTO-825 Gene Therapy at ASGCT Annual Meeting Apr 19, 2021 Otonomy Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares Apr 07, 2021 Otonomy Announces Pricing of $30.1 Million Public Offering Apr 07, 2021 Otonomy Announces Proposed Public Offering Apr 06, 2021 Otonomy to Present at the Needham Virtual Healthcare Conference Apr 05, 2021 Otonomy Announces Presentation of OTO-313 Clinical Results at American Neurotology Society Annual Meeting Pagination Current page 1 Page 2 Next page next › Last page last »
